Literature DB >> 16523000

Hypertension and kidney damage.

Karen A Griffin1.   

Abstract

Substantial evidence indicates that hypertension is a major contributor to the development of end-stage renal disease in most patients. However, such risk ranges from being fairly low in essential hypertension to a marked increase in susceptibility to hypertensive injury in patients with chronic kidney disease, including diabetic nephropathy. Studies in experimental animal models using blood pressure radiotelemetry have provided significant insights into the quantitative relationships between blood pressure and renal damage and the importance of protective renal autoregulatory capacity as a determinant of such differences in susceptibility to hypertensive injury. Moreover, such investigations have also emphasized the predominant importance of achieving normotension per se over the selection of particular antihypertensive regimens, including renin-angiotensin system blockade, in slowing the progression of chronic kidney disease.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16523000      PMCID: PMC8109389          DOI: 10.1111/j.1524-6175.2005.05111.x

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  18 in total

1.  Comparative effects of ramipril on ambulatory and office blood pressures: a HOPE Substudy.

Authors:  P Svensson; U de Faire; P Sleight; S Yusuf; J Ostergren
Journal:  Hypertension       Date:  2001-12-01       Impact factor: 10.190

2.  Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

Authors: 
Journal:  JAMA       Date:  2002-12-18       Impact factor: 56.272

3.  Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

Authors:  Mahboob Rahman; Sara Pressel; Barry R Davis; Chuke Nwachuku; Jackson T Wright; Paul K Whelton; Joshua Barzilay; Vecihi Batuman; John H Eckfeldt; Michael Farber; Mario Henriquez; Nelson Kopyt; Gail T Louis; Mohammad Saklayen; Carol Stanford; Candace Walworth; Harry Ward; Thomas Wiegmann
Journal:  Arch Intern Med       Date:  2005-04-25

4.  Renal autoregulation and vulnerability to hypertensive injury in remnant kidney.

Authors:  A K Bidani; M M Schwartz; E J Lewis
Journal:  Am J Physiol       Date:  1987-06

Review 5.  Pathophysiology of hypertensive renal damage: implications for therapy.

Authors:  Anil K Bidani; Karen A Griffin
Journal:  Hypertension       Date:  2004-09-27       Impact factor: 10.190

6.  The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  JAMA       Date:  2003-05-14       Impact factor: 56.272

7.  Low protein diet mediated renoprotection in remnant kidneys: Renal autoregulatory versus hypertrophic mechanisms.

Authors:  Karen A Griffin; Maria Picken; Anita Giobbie-Hurder; Anil K Bidani
Journal:  Kidney Int       Date:  2003-02       Impact factor: 10.612

8.  Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials.

Authors:  Fiona Turnbull
Journal:  Lancet       Date:  2003-11-08       Impact factor: 79.321

9.  Radiotelemetric BP monitoring, antihypertensives and glomeruloprotection in remnant kidney model.

Authors:  K A Griffin; M Picken; A K Bidani
Journal:  Kidney Int       Date:  1994-10       Impact factor: 10.612

Review 10.  Effect of inhibitors of the renin-angiotensin system and other antihypertensive drugs on renal outcomes: systematic review and meta-analysis.

Authors:  Juan P Casas; Weiliang Chua; Stavros Loukogeorgakis; Patrick Vallance; Liam Smeeth; Aroon D Hingorani; Raymond J MacAllister
Journal:  Lancet       Date:  2005-12-10       Impact factor: 79.321

View more
  6 in total

Review 1.  Regulatory mechanism of "K+recycling" for Na +reabsorption in renal tubules.

Authors:  Masayuki Tanemoto
Journal:  Clin Exp Nephrol       Date:  2007-03-28       Impact factor: 2.801

2.  Kidney fibrosis in hypertensive rats: role of oxidative stress.

Authors:  Wenyuan Zhao; Sue S Chen; Yuanjian Chen; Robert A Ahokas; Yao Sun
Journal:  Am J Nephrol       Date:  2008-02-01       Impact factor: 3.754

3.  β-Catenin-Dependent Signaling Pathway Contributes to Renal Fibrosis in Hypertensive Rats.

Authors:  Catherina A Cuevas; Cheril Tapia-Rojas; Carlos Cespedes; Nibaldo C Inestrosa; Carlos P Vio
Journal:  Biomed Res Int       Date:  2015-04-07       Impact factor: 3.411

4.  Association of Nonsteroidal Anti-inflammatory Drug Prescriptions With Kidney Disease Among Active Young and Middle-aged Adults.

Authors:  D Alan Nelson; Eric S Marks; Patricia A Deuster; Francis G O'Connor; Lianne M Kurina
Journal:  JAMA Netw Open       Date:  2019-02-01

5.  Development of a unilateral ureteral obstruction model in cynomolgus monkeys.

Authors:  Linghong Huang; Jia Ni; Tanika Duncan; Zhizhan Song; Timothy S Johnson
Journal:  Animal Model Exp Med       Date:  2021-11-19

Review 6.  Arterial Stiffness, Kidney Function, and Chronic Kidney Disease Progression.

Authors:  Raymond R Townsend; Hirofumi Tomiyama
Journal:  Pulse (Basel)       Date:  2013-09-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.